The Claim
A fragment-based drug discovery approach identified small molecules that bind to the active site of INO1 and inhibit its enzymatic activity, demonstrating the feasibility of applying pharmaceutical screening methods to crop improvement.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Researchers used drug discovery techniques to find small molecules that bind to and reduce the activity of the INO1 enzyme in plants, showing that pharmaceutical screening methods can be adapted to enhance crop traits.
See the scientific wording
A fragment-based drug discovery approach successfully identified small molecules that bind to the active site of INO1 and inhibit its enzymatic activity, demonstrating feasibility of applying pharmaceutical screening methods to crop improvement.
Tiny chemical molecules bind to a specific spot on a plant enzyme called INO1, stopping it from making a key building block needed to produce phytic acid. Without this building block, the plant can't make much phytic acid in its seeds. Since phytic acid normally traps minerals like iron and zinc, less of it means those minerals stay free and can be absorbed by people who eat the grains.
What the research says
1 studyScientists used the same method drug companies use to find medicines to find tiny chemicals that block a plant enzyme called INO1. This made the grains of rice and wheat have less phytic acid, which helps people absorb more iron and zinc from their food.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.